68 days to first decision for reviewed manuscripts only
41 days to first decision for all manuscripts
147 days from submission to acceptance
12 days from acceptance to publication

All aspects of cheminformatics and molecular modelling
chemical information systems, software and databases, and molecular modelling
chemical structure representations and their use in structure, substructure, and similarity searching of chemical substance and chemical reaction databases
computer and molecular graphics, computer-aided molecular design, expert systems, QSAR, and data mining techniques

Research article
Book report
Commentary
Database
Meeting report
Methodology
Preliminary communication
Review
Software
Educational
Letter to the Editor

Editors-in-Chief
Rajarshi GuhaVertex Pharmaceuticals, USA 
Rajarshi Guha is the Associate Director of Informatics at Vertex Pharmaceuticals where he leads the cheminformatics group that is responsible for informatics needs in high throughput screening, library design & enhancement and in vitro toxicology. Prior to joining Vertex, he spent 9 years at as a research scientist in the Division of Pre-Clinical Innovation at NCATS. His work has ranged from small molecule development projects in a variety of therapeutic areas (including rare cancers and infectious diseases) to software and algorithm development in the areas of cheminformatics methods and large-scale infrastructure projects including Pharos, BARD and the Trans-NIH RNAi Screening Facility.
His research interests focus on method & infrastructure development to analyze and visualize chemical biology datasets, with specific focus on techniques to link chemical structure information to molecular, bibliographic, genomic and clinical covariates to explain the effects of small molecules in the context of larger biological systems.

Egon WillighagenMaastricht University, Netherlands 
Egon Willighagen is a researcher in the BiGCaT Department for Bioinformatics and teacher at Maastricht University in the Netherlands. His research projects focus on using and developing new cheminformatics and chemometrics approaches to explain biological phenomena in metabolic diseases, drug discovery, and toxicology.
The research develops and contributes to open source and open data projects including BridgeDb, eNanoMapper, the Chemistry Development Kit (CDK), Bioclipse, and linked open data projects such as WikiPathways, the CHEMINF ontology, and Open PHACTS.

Associate Editors
Nina JeliazkovaIdea Consult Ltd., Bulgaria 

Founding Editors-in-Chief
Christoph SteinbeckFriedrich-Schiller-University, Germany 
David J WildIndiana University, USA 

Editorial Board
Dimitris AgrafiotisCovance, USA 
Michael R BertholdUniversity of Konstanz, Germany 
Evan BoltonNIH, USA 
Curt BrenemanRensselaer Polytechnic Institute, USA
Robert ClarkSimulations Plus, Inc., USA 
Peter ErtlNovartis, Switzerland 
Jeremy FreyUniversity of Southampton, UK 
Val Gillet University of Sheffield, UK 
Robert Glen University of Cambridge, UK 
Jonathan GoodmanUniversity of Cambridge, UK 
Steve HellerNIST, USA
Tingjun HouZhejiang University, China 
Geoffrey HutchisonUniversity of Pittsburgh, USA 
Dušanka JanežičUniversity of Primorska, Slovenia 
Michael Lajiness Eli Lilly & Co., USA 
Yvonne MartinMartin Consulting, USA 
Emma Schymanski University of Luxembourg, Luxembourg 
Ola SpjuthUppsala University, Sweden 
Alexander TropshaUniversity of North Carolina - Chapel Hill, USA 
John Van Drie Van Drie Research LLC, USA
Martin WalkerState University of New York Potsdam, USA 
Wendy WarrWendy Warr & Associates, UK 
Ian Watson Eli Lilly & Co., USA 
Antony WilliamsUS Environmental Protection Agency, USA